Articles From: Intercept Pharmaceuticals to Host 2013 Full Year Financial Results and Business Update Conference Call on March 17 to InterCloud Systems Announces the Appointment of Scott Davis as Senior Vice President of Sales and Marketing


2014/3/10
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases, today announced that it will report 2013 full year financial results after the NASDAQ Market closes on Friday, March 14, 2014.
Sign-up for Intercept Pharmaceuticals to Host 2013 Full Year Financial Results and Business Update Conference Call on March 17 investment picks
2014/1/22
ADVISORY, Jan.
Sign-up for Intercept Pharmaceuticals, Inc. [ICPT] to Ring The NASDAQ Stock Market Closing Bell investment picks
2014/1/9
NEW YORK, Jan.
Sign-up for Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones investment picks
2014/1/12
NEW YORK, Jan.
Sign-up for Intercept Reports Additional Details About FLINT Trial Provided by NIDDK investment picks
2014/4/12
-Notable Improvements on Key Endpoints as Early as Two Weeks After OCA Treatment Initiation -Titration Regimen Well Tolerated With Pruritus Incidence and Severity Diminishing Over Course of Treatment NEW YORK, April 12, 2014 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced efficacy and safety results from the Phase 3 POISE trial of obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBC) to be presented in a late-breaker session at the International Liver Congress of the European Association for the Study of the Liver (EASL). OCA, Intercept's lead product candidate, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR) in development for PBC, nonalcoholic steatohepatitis (NASH) and other liver and intestinal diseases.
Sign-up for Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session investment picks
2014/2/5
NEW YORK, Feb.
Sign-up for Intercept to Present at Leerink Global Healthcare Conference investment picks
2014/1/10
NEW YORK, Jan.
Sign-up for Intercept to Present at the J.P. Morgan Healthcare Conference investment picks
2014/2/18
NEW YORK, Feb.
Sign-up for Intercept to Present at Upcoming Healthcare Conferences investment picks
2014/1/13
NEW YORK (MarketWatch) -- Shares in Intercept Pharmaceuticals Inc. (ICPT) dived 25% in premarket action on Monday, giving up some of their giant gains from last week that came after positive news about an experimental liver-disease drug.
Sign-up for Intercept, Celgene on move amid J.P. Morgan event investment picks
2014/1/13
NEW YORK (MarketWatch) -- Shares of Intercept Pharmaceuticals Inc. (ICPT), Lululemon Athletica Inc. (LULU) and SodaStream International Ltd.
Sign-up for Intercept, Lululemon, SodaStream shares slump investment picks
2013/12/13
RED BANK, N.J., Dec.
Sign-up for InterCloud Announces Agreement to Acquire Integration Partners-NY Corp. and $11,625,000 Convertible Debenture Financing investment picks
2014/3/31
RED BANK, N.J., March 31, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems Incorporate (Nasdaq:ICLD) ("InterCloud" or the "Company"), announced today it intends to report its Fourth Quarter 2013 and 2013 Annual Report on Form 10K on Monday, April 7, 2014.
Sign-up for InterCloud Announces Conference Call to Discuss Fiscal 2013 Financial Results investment picks
RED BANK, N.J., Nov.
Sign-up for InterCloud Announces Conference Call to Discuss Third Quarter Financial Results investment picks
2014/1/31
RED BANK, N.J., Jan.
Sign-up for InterCloud Announces New Managed Service Agreement With the Brooklyn Hospital Center (TBHC) investment picks
2014/1/28
RED BANK, N.J., Jan.
Sign-up for InterCloud Announces the Appointment of Industry Veteran Frank Jadevaia as President investment picks
2014/1/2
RED BANK, N.J., Jan.
Sign-up for InterCloud Announces the Completion of Its Acquisition of Integration Partners-NY Corp. investment picks
BOCA RATON, Fla., Nov.
Sign-up for InterCloud Awarded Over $2.5 Million in New Professional Services Contracts investment picks
2014/1/3
RED BANK, NJ., Jan.
Sign-up for InterCloud Awarded Up to $7 Million in New Professional Services Contracts investment picks
2013/12/2
RED BANK, N.J., Dec.
Sign-up for InterCloud Continues to Reduce Balance Sheet Liabilities investment picks
2014/4/11
SHREWSBURY, N.J., April 11, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) , a single-source provider of end-to end IT and next generation network solutions to the service provider and corporate enterprise markets through cloud platforms and professional services, announced today that it was awarded two new major design contracts for small cell deployment.
Sign-up for InterCloud Contracts for Small Cell Network Deployment investment picks
2014/3/12
RED BANK, N.J., March 12, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) ("InterCloud" or the "Company") announced today that it entered into an Exchange Agreement (the "Agreement") with the holders of those certain debt securities issued by the Company in September 2012 (the "MidMarket Debt"). The Agreement provided for the exchange (the "Exchange") of all of the MidMarket Debt for shares of Company common stock, par value $0.0001 ("Common Stock").  The Company completed the Exchange effective March 12, 2014 (the "Closing Date"). Pursuant to the Exchange, the Company exchanged senior secured debt amounting to an aggregate of approximately $12.6 million of principal and accrued interest, for 1,204,410 shares of Common Stock subject to certain one time adjustments, reflecting a per share value of $10.50.  The shares of Company common stock were issued pursuant to an available exemption from registration under the Securities Act of 1933, as
Sign-up for InterCloud Eliminates $12.6 Million of Senior Debt investment picks
RED BANK, N.J., Nov.
Sign-up for InterCloud Eliminates More Than $6 Million in Balance Sheet Liabilities investment picks
2014/1/8
RED BANK, N.J., Jan.
Sign-up for InterCloud Reduces Debt and Strengthens Balance Sheet investment picks
2014/3/28
RED BANK, N.J., March 28, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) ("InterCloud" or the "Company") became aware last week of allegations made on a website known as the Southern Investigative Reporting Foundation ("SIRF") that the Company purportedly paid certain people to write articles and make certain alleged misrepresentations about the Company.
Sign-up for InterCloud Refutes Allegations Made Against the Company investment picks
2014/3/10
RED BANK, N.J., March 10, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) (the "Company" or "InterCloud"), announced today an agreement with the Jewish Board of Family and Children's Services ("JBFCS") to provide a total migration from their legacy voice, data and network security systems to next-generation unified communications (UC), network security and advanced data switching and routing architectures.
Sign-up for InterCloud Systems Announces a New Turnkey Managed Services Agreement With the Jewish Board of Family and Children's Services investment picks
2014/3/3
RED BANK, N.J., March 3, 2014 (GLOBE NEWSWIRE) -- InterCloud Systems, Inc. (Nasdaq:ICLD) (the "Company" or "InterCloud"), today formally announced the appointment of Scott Davis as Senior Vice President of Sales and Marketing.
Sign-up for InterCloud Systems Announces the Appointment of Scott Davis as Senior Vice President of Sales and Marketing investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Intercept Pharmaceuticals to Host 2013 Full Year Financial Results and Business Update Conference Call on March 17 to InterCloud Systems Announces the Appointment of Scott Davis as Senior Vice President of Sales and Marketing
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity